How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> G7 Countries Prioritise Primary Health Care At Health Ministers’ Meeting In Paris 17/05/2019 David Branigan Health Ministers from G7 countries wrapped up a two-day meeting today in Paris that focused on strengthening primary health care, health inequalities for developing countries and the elimination of HIV/AIDS, tuberculosis and malaria. Image Credits: G7 France. Continue reading -> UNAIDS Calls On Countries To Change Laws That Hinder Access To Health For LGBTI People 16/05/2019 David Branigan UNAIDS calls on all countries to remove laws that discriminate against lesbian, gay, bisexual, transgender and intersex (LGBTI) people, and to enact laws that protect them, in order to ensure that all people have full access to health services for HIV/AIDS. Image Credits: UNAIDS. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access 13/05/2019 William New Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from the 10 May closed-door informal negotiations at the WHO, and shows progress toward compromise among member states. Continue reading -> Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> G7 Countries Prioritise Primary Health Care At Health Ministers’ Meeting In Paris 17/05/2019 David Branigan Health Ministers from G7 countries wrapped up a two-day meeting today in Paris that focused on strengthening primary health care, health inequalities for developing countries and the elimination of HIV/AIDS, tuberculosis and malaria. Image Credits: G7 France. Continue reading -> UNAIDS Calls On Countries To Change Laws That Hinder Access To Health For LGBTI People 16/05/2019 David Branigan UNAIDS calls on all countries to remove laws that discriminate against lesbian, gay, bisexual, transgender and intersex (LGBTI) people, and to enact laws that protect them, in order to ensure that all people have full access to health services for HIV/AIDS. Image Credits: UNAIDS. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access 13/05/2019 William New Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from the 10 May closed-door informal negotiations at the WHO, and shows progress toward compromise among member states. Continue reading -> Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> G7 Countries Prioritise Primary Health Care At Health Ministers’ Meeting In Paris 17/05/2019 David Branigan Health Ministers from G7 countries wrapped up a two-day meeting today in Paris that focused on strengthening primary health care, health inequalities for developing countries and the elimination of HIV/AIDS, tuberculosis and malaria. Image Credits: G7 France. Continue reading -> UNAIDS Calls On Countries To Change Laws That Hinder Access To Health For LGBTI People 16/05/2019 David Branigan UNAIDS calls on all countries to remove laws that discriminate against lesbian, gay, bisexual, transgender and intersex (LGBTI) people, and to enact laws that protect them, in order to ensure that all people have full access to health services for HIV/AIDS. Image Credits: UNAIDS. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access 13/05/2019 William New Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from the 10 May closed-door informal negotiations at the WHO, and shows progress toward compromise among member states. Continue reading -> Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Several Ministers Of Health Speak Up For Drug Market Transparency, Lower Prices At WHA Side Event 20/05/2019 Catherine Saez The room holding the high-level side event on transparency of pharmaceutical product markets was overflowing today – with dozens of people standing to hear the speakers – many of them ministers of health, reflecting the importance of the topic at the 72nd World Health Assembly. Image Credits: Catherine Saez. Continue reading -> G7 Countries Prioritise Primary Health Care At Health Ministers’ Meeting In Paris 17/05/2019 David Branigan Health Ministers from G7 countries wrapped up a two-day meeting today in Paris that focused on strengthening primary health care, health inequalities for developing countries and the elimination of HIV/AIDS, tuberculosis and malaria. Image Credits: G7 France. Continue reading -> UNAIDS Calls On Countries To Change Laws That Hinder Access To Health For LGBTI People 16/05/2019 David Branigan UNAIDS calls on all countries to remove laws that discriminate against lesbian, gay, bisexual, transgender and intersex (LGBTI) people, and to enact laws that protect them, in order to ensure that all people have full access to health services for HIV/AIDS. Image Credits: UNAIDS. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access 13/05/2019 William New Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from the 10 May closed-door informal negotiations at the WHO, and shows progress toward compromise among member states. Continue reading -> Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
G7 Countries Prioritise Primary Health Care At Health Ministers’ Meeting In Paris 17/05/2019 David Branigan Health Ministers from G7 countries wrapped up a two-day meeting today in Paris that focused on strengthening primary health care, health inequalities for developing countries and the elimination of HIV/AIDS, tuberculosis and malaria. Image Credits: G7 France. Continue reading -> UNAIDS Calls On Countries To Change Laws That Hinder Access To Health For LGBTI People 16/05/2019 David Branigan UNAIDS calls on all countries to remove laws that discriminate against lesbian, gay, bisexual, transgender and intersex (LGBTI) people, and to enact laws that protect them, in order to ensure that all people have full access to health services for HIV/AIDS. Image Credits: UNAIDS. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access 13/05/2019 William New Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from the 10 May closed-door informal negotiations at the WHO, and shows progress toward compromise among member states. Continue reading -> Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UNAIDS Calls On Countries To Change Laws That Hinder Access To Health For LGBTI People 16/05/2019 David Branigan UNAIDS calls on all countries to remove laws that discriminate against lesbian, gay, bisexual, transgender and intersex (LGBTI) people, and to enact laws that protect them, in order to ensure that all people have full access to health services for HIV/AIDS. Image Credits: UNAIDS. Continue reading -> WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access 13/05/2019 William New Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from the 10 May closed-door informal negotiations at the WHO, and shows progress toward compromise among member states. Continue reading -> Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Launches Health Product Profile Directory To Stimulate New Drug Research 16/05/2019 Elaine Ruth Fletcher The World Health Organization has launched an online Health Product Profile Directory to guide the development of new health products for which there are limited markets or incentives for research and development. Image Credits: WHO. Continue reading -> Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access 13/05/2019 William New Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from the 10 May closed-door informal negotiations at the WHO, and shows progress toward compromise among member states. Continue reading -> Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access 13/05/2019 William New Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects changes from the 10 May closed-door informal negotiations at the WHO, and shows progress toward compromise among member states. Continue reading -> Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> Posts navigation Older postsNewer posts